advertisement
Abstract #100379 Published in IGR 23-1
Adherence to Therapy in Glaucoma Treatment-A Review
Zaharia AC; Zaharia AC; Dumitrescu OM; Dumitrescu OM; Radu M; Rogoz REJournal of personalized medicine 2022; 12:
Glaucoma is a chronic disease and the second leading cause of irreversible vision loss worldwide, whose initial treatment consists of self-administered topical ocular hypotensive eyedrops. Adherence with glaucoma medications is a fundamental problem in the care of glaucoma patients as up to 50% of patients fail to receive the intended benefits of the treatment. The literature has identified many barriers to patients' compliance, from factors depending on the type of medication administered, communication between physician and patients, to factors dependent on patients' behaviour and lifestyle. Failure to take medication as prescribed increases the risk that patients will not receive the desired benefit, which often leads to a worsening of the disease. Our aim is to synthesize the methods used for measuring adherence of patients to glaucoma therapy and the interventions used for addressing adherence, laying emphasis on a patient-centred approach, taking time to educate patients about their chronic disease and to assess their views on treatment.
Department of Ophthalmology, "Dr. Carol Davila" Central Military Emergency Hospital, 010825 Bucharest, Romania.
Full article